{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:15:41Z","timestamp":1791249341324,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T00:00:00Z","timestamp":1653436800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T00:00:00Z","timestamp":1653436800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-022-01821-7","type":"journal-article","created":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T04:02:31Z","timestamp":1653451351000},"page":"1899-1908","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Cost-effectiveness of adrenal vein sampling- vs computed tomography-guided adrenalectomy for unilateral adrenaloma in primary aldosteronism"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3269-648X","authenticated-orcid":false,"given":"S.","family":"Arjani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. J.","family":"Bostonian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4742-8552","authenticated-orcid":false,"given":"V.","family":"Prasath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4133-2768","authenticated-orcid":false,"given":"P. L.","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2547-4942","authenticated-orcid":false,"given":"R. J.","family":"Chokshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,25]]},"reference":[{"issue":"5","key":"1821_CR1","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","volume":"101","author":"JW Funder","year":"2016","unstructured":"Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, Stowasser M, Young WF Jr (2016) The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 101(5):1889\u20131916. https:\/\/doi.org\/10.1210\/jc.2015-4061","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"1821_CR2","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","volume":"48","author":"GP Rossi","year":"2006","unstructured":"Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, Ganzaroli C, Giacchetti G, Letizia C, Maccario M, Mallamaci F, Mannelli M, Mattarello MJ, Moretti A, Palumbo G, Parenti G, Porteri E, Semplicini A, Rizzoni D, Rossi E, Boscaro M, Pessina AC, Mantero F (2006) A prospective study of the prevalence of primary aldosteronism in 1125 hypertensive patients. J Am Coll Cardiol 48(11):2293\u20132300. https:\/\/doi.org\/10.1016\/j.jacc.2006.07.059","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"1821_CR3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/s2213-8587(17)30319-4","volume":"6","author":"S Monticone","year":"2018","unstructured":"Monticone S, D\u2019Ascenzo F, Moretti C, Williams TA, Veglio F, Gaita F, Mulatero P (2018) Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. Lancet Diabetes Endocrinol 6(1):41\u201350. https:\/\/doi.org\/10.1016\/s2213-8587(17)30319-4","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"12","key":"1821_CR4","doi-asserted-by":"publisher","first-page":"4826","DOI":"10.1210\/jc.2013-2805","volume":"98","author":"P Mulatero","year":"2013","unstructured":"Mulatero P, Monticone S, Bertello C, Viola A, Tizzani D, Iannaccone A, Crudo V, Burrello J, Milan A, Rabbia F, Veglio F (2013) Long-term cardio- and cerebrovascular events in patients with primary aldosteronism. J Clin Endocrinol Metab 98(12):4826\u20134833. https:\/\/doi.org\/10.1210\/jc.2013-2805","journal-title":"J Clin Endocrinol Metab"},{"issue":"22","key":"1821_CR5","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1001\/jama.295.22.2638","volume":"295","author":"LA Sechi","year":"2006","unstructured":"Sechi LA, Novello M, Lapenna R, Baroselli S, Nadalini E, Colussi GL, Catena C (2006) Long-term renal outcomes in patients with primary aldosteronism. JAMA 295(22):2638\u20132645. https:\/\/doi.org\/10.1001\/jama.295.22.2638","journal-title":"JAMA"},{"key":"1821_CR6","doi-asserted-by":"publisher","first-page":"32103","DOI":"10.1038\/srep32103","volume":"6","author":"VC Wu","year":"2016","unstructured":"Wu VC, Wang SM, Chang CH, Hu YH, Lin LY, Lin YH, Chueh SC, Chen L, Wu KD (2016) Long term outcome of aldosteronism after target treatments. Sci Rep 6:32103. https:\/\/doi.org\/10.1038\/srep32103","journal-title":"Sci Rep"},{"issue":"3","key":"1821_CR7","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1161\/hypertensionaha.118.11382","volume":"72","author":"TA Williams","year":"2018","unstructured":"Williams TA, Burrello J, Sechi LA, Fardella CE, Matrozova J, Adolf C, Baudrand R, Bernardi S, Beuschlein F, Catena C, Doumas M, Fallo F, Giacchetti G, Heinrich DA, Saint-Hilary G, Jansen PM, Januszewicz A, Kocjan T, Nishikawa T, Quinkler M, Satoh F, Umakoshi H, Widimsk\u00fd J Jr, Hahner S, Douma S, Stowasser M, Mulatero P, Reincke M (2018) Computed tomography and adrenal venous sampling in the diagnosis of unilateral primary aldosteronism. Hypertension 72(3):641\u2013649. https:\/\/doi.org\/10.1161\/hypertensionaha.118.11382","journal-title":"Hypertension"},{"issue":"9","key":"1821_CR8","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/s2213-8587(17)30135-3","volume":"5","author":"TA Williams","year":"2017","unstructured":"Williams TA, Lenders JWM, Mulatero P, Burrello J, Rottenkolber M, Adolf C, Satoh F, Amar L, Quinkler M, Deinum J, Beuschlein F, Kitamoto KK, Pham U, Morimoto R, Umakoshi H, Prejbisz A, Kocjan T, Naruse M, Stowasser M, Nishikawa T, Young WF Jr, Gomez-Sanchez CE, Funder JW, Reincke M (2017) Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. Lancet Diabetes Endocrinol 5(9):689\u2013699. https:\/\/doi.org\/10.1016\/s2213-8587(17)30135-3","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"22","key":"1821_CR9","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1016\/j.jacc.2019.09.057","volume":"74","author":"GP Rossi","year":"2019","unstructured":"Rossi GP (2019) Primary aldosteronism: Jacc state-of-the-art review. J Am Coll Cardiol 74(22):2799\u20132811. https:\/\/doi.org\/10.1016\/j.jacc.2019.09.057","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"1821_CR10","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/s2213-8587(16)30100-0","volume":"4","author":"T Dekkers","year":"2016","unstructured":"Dekkers T, Prejbisz A, Kool LJS, Groenewoud H, Velema M, Spiering W, Ko\u0142odziejczyk-Kruk S, Arntz M, K\u0105dziela J, Langenhuijsen JF, Kerstens MN, van den Meiracker AH, van den Born BJ, Sweep F, Hermus A, Januszewicz A, Ligthart-Naber AF, Makai P, van der Wilt GJ, Lenders JWM, Deinum J (2016) Adrenal vein sampling versus ct scan to determine treatment in primary aldosteronism: an outcome-based randomised diagnostic trial. Lancet Diabetes Endocrinol 4(9):739\u2013746. https:\/\/doi.org\/10.1016\/s2213-8587(16)30100-0","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"1821_CR11","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1210\/jc.2011-2830","volume":"97","author":"GP Rossi","year":"2012","unstructured":"Rossi GP, Barisa M, Allolio B, Auchus RJ, Amar L, Cohen D, Degenhart C, Deinum J, Fischer E, Gordon R, Kickuth R, Kline G, Lacroix A, Magill S, Miotto D, Naruse M, Nishikawa T, Omura M, Pimenta E, Plouin PF, Quinkler M, Reincke M, Rossi E, Rump LC, Satoh F, Schultze Kool L, Seccia TM, Stowasser M, Tanabe A, Trerotola S, Vonend O, Widimsky J Jr, Wu KD, Wu VC, Pessina AC (2012) The adrenal vein sampling international study (avis) for identifying the major subtypes of primary aldosteronism. J Clin Endocrinol Metab 97(5):1606\u20131614. https:\/\/doi.org\/10.1210\/jc.2011-2830","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1821_CR12","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1161\/HYPERTENSIONAHA.117.09294","volume":"71","author":"J Deinum","year":"2018","unstructured":"Deinum J, Prejbisz A, Lenders JWM, van der Wilt GJ (2018) Adrenal vein sampling is the preferred method to select patients with primary aldosteronism for adrenalectomy. Hypertension 71(1):10\u201314. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.117.09294","journal-title":"Hypertension"},{"issue":"5","key":"1821_CR13","doi-asserted-by":"publisher","first-page":"227","DOI":"10.4330\/wjc.v6.i5.227","volume":"6","author":"A Aronova","year":"2014","unstructured":"Aronova A, Fahey TJ III, Zarnegar R (2014) Management of hypertension in primary aldosteronism. World J Cardiol 6(5):227\u2013233. https:\/\/doi.org\/10.4330\/wjc.v6.i5.227","journal-title":"World J Cardiol"},{"issue":"Suppl 1","key":"1821_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4158\/ep.15.S1.1","volume":"15","author":"MA Zeiger","year":"2009","unstructured":"Zeiger MA, Thompson GB, Duh QY, Hamrahian AH, Angelos P, Elaraj D, Fishman E, Kharlip J (2009) The American association of clinical endocrinologists and American association of endocrine surgeons medical guidelines for the management of adrenal incidentalomas. Endocr Pract 15(Suppl 1):1\u201320. https:\/\/doi.org\/10.4158\/ep.15.S1.1","journal-title":"Endocr Pract"},{"issue":"2","key":"1821_CR15","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jss.2012.07.059","volume":"177","author":"Y Carter","year":"2012","unstructured":"Carter Y, Roy M, Sippel RS, Chen H (2012) Persistent hypertension after adrenalectomy for an aldosterone-producing adenoma: weight as a critical prognostic factor for aldosterone\u2019s lasting effect on the cardiac and vascular systems. J Surg Res 177(2):241\u2013247. https:\/\/doi.org\/10.1016\/j.jss.2012.07.059","journal-title":"J Surg Res"},{"issue":"1","key":"1821_CR16","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1001\/archinternmed.2007.33","volume":"168","author":"C Catena","year":"2008","unstructured":"Catena C, Colussi G, Nadalini E, Chiuch A, Baroselli S, Lapenna R, Sechi LA (2008) Cardiovascular outcomes in patients with primary aldosteronism after treatment. Arch Intern Med 168(1):80\u201385. https:\/\/doi.org\/10.1001\/archinternmed.2007.33","journal-title":"Arch Intern Med"},{"issue":"1","key":"1821_CR17","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/s2213-8587(17)30367-4","volume":"6","author":"GL Hundemer","year":"2018","unstructured":"Hundemer GL, Curhan GC, Yozamp N, Wang M, Vaidya A (2018) Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study. Lancet Diabetes Endocrinol 6(1):51\u201359. https:\/\/doi.org\/10.1016\/s2213-8587(17)30367-4","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1821_CR18","unstructured":"Defined daily dose: definition and general considerations. https:\/\/www.who.int\/tools\/atc-ddd-toolkit\/about-ddd. Accessed 8 May 2021"},{"key":"1821_CR19","unstructured":"CY (2021) Medicare physician fee schedule final rule. Centers for Medicare & Medicaid Services. https:\/\/www.cms.gov\/Medicare\/Medicare-Fee-for-Service-Payment\/PhysicianFeeSched. Accessed 8 May 2021"},{"issue":"6","key":"1821_CR20","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1161\/circoutcomes.115.002002","volume":"8","author":"CC Lubitz","year":"2015","unstructured":"Lubitz CC, Economopoulos KP, Sy S, Johanson C, Kunzel HE, Reincke M, Gazelle GS, Weinstein MC, Gaziano TA (2015) Cost-effectiveness of screening for primary aldosteronism and subtype diagnosis in the resistant hypertensive patients. Circ Cardiovasc Qual Outcomes 8(6):621\u2013630. https:\/\/doi.org\/10.1161\/circoutcomes.115.002002","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"6","key":"1821_CR21","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/j.surg.2010.09.012","volume":"148","author":"B Reimel","year":"2010","unstructured":"Reimel B, Zanocco K, Russo MJ, Zarnegar R, Clark OH, Allendorf JD, Chabot JA, Duh QY, Lee JA, Sturgeon C (2010) The management of aldosterone-producing adrenal adenomas\u2013does adrenalectomy increase costs? Surgery 148(6):1178\u20131185. https:\/\/doi.org\/10.1016\/j.surg.2010.09.012 (Discussion 1185)","journal-title":"Surgery"},{"issue":"11","key":"1821_CR22","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1055\/s-0035-1559645","volume":"47","author":"M Sato","year":"2015","unstructured":"Sato M, Morimoto R, Seiji K, Iwakura Y, Ono Y, Kudo M, Satoh F, Ito S, Ishibashi T, Takase K (2015) Cost-effectiveness analysis of the diagnosis and treatment of primary aldosteronism in Japan. Horm Metab Res 47(11):826\u2013832. https:\/\/doi.org\/10.1055\/s-0035-1559645","journal-title":"Horm Metab Res"},{"issue":"9","key":"1821_CR23","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1111\/jch.12570","volume":"17","author":"A Velasco","year":"2015","unstructured":"Velasco A, Chung O, Raza F, Pandey A, Brinker S, Arbique D, Price A, Lotan Y, Das SR, Vongpatanasin W (2015) Cost-effectiveness of therapeutic drug monitoring in diagnosing primary aldosteronism in patients with resistant hypertension. J Clin Hypertens 17(9):713\u2013719. https:\/\/doi.org\/10.1111\/jch.12570","journal-title":"J Clin Hypertens"},{"issue":"2","key":"1821_CR24","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1177\/0272989X8900900210","volume":"9","author":"LJA Stalpers","year":"1989","unstructured":"Stalpers LJA, Van Gasteren HJM, Van Daal WAJ (1989) Deale-ing with life expectancy and mortality rates. Med Decis Making 9(2):150\u2013152. https:\/\/doi.org\/10.1177\/0272989X8900900210","journal-title":"Med Decis Making"},{"key":"1821_CR25","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3389\/fendo.2020.00121","volume":"11","author":"Z Meng","year":"2020","unstructured":"Meng Z, Dai Z, Huang K, Xu C, Zhang YG, Zheng H, Liu TZ (2020) Long-term mortality for patients of primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. Front Endocrinol 11:121. https:\/\/doi.org\/10.3389\/fendo.2020.00121","journal-title":"Front Endocrinol"},{"issue":"2","key":"1821_CR26","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1161\/01.HYP.0000173433.67426.9b","volume":"46","author":"OH Franco","year":"2005","unstructured":"Franco OH, Peeters A, Bonneux L, de Laet C (2005) Blood pressure in adulthood and life expectancy with cardiovascular disease in men and women: life course analysis. Hypertension 46(2):280\u2013286. https:\/\/doi.org\/10.1161\/01.HYP.0000173433.67426.9b","journal-title":"Hypertension"},{"issue":"1","key":"1821_CR27","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1210\/jc.2017-01442","volume":"103","author":"M Velema","year":"2018","unstructured":"Velema M, Dekkers T, Hermus A, Timmers H, Lenders J, Groenewoud H, Schultze Kool L, Langenhuijsen J, Prejbisz A, van der Wilt GJ, Deinum J (2018) Quality of life in primary aldosteronism: a comparative effectiveness study of adrenalectomy and medical treatment. J Clin Endocrinol Metab 103(1):16\u201324. https:\/\/doi.org\/10.1210\/jc.2017-01442","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"1821_CR28","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1056\/NEJMp1405158","volume":"371","author":"PJ Neumann","year":"2014","unstructured":"Neumann PJ, Cohen JT, Weinstein MC (2014) Updating cost-effectiveness\u2014the curious resilience of the $50,000-per-qaly threshold. N Engl J Med 371(9):796\u2013797. https:\/\/doi.org\/10.1056\/NEJMp1405158","journal-title":"N Engl J Med"},{"key":"1821_CR29","unstructured":"Survival parametric conversion tool, in National Statistical Stoftware, NCSS, LLC. https:\/\/ncss-wpengine.netdna-ssl.com\/wp-content\/themes\/ncss\/pdf\/Procedures\/NCSS\/Survival_Parameter_Conversion_Tool.pdf. Accessed 7 May 2021"},{"key":"1821_CR30","unstructured":"Actuarial Life Table (2017) O.o.t.C.A. Staff, Editor, Social security administration. https:\/\/www.ssa.gov\/oact\/STATS\/table4c6.html. Accessed 5 May 2021"},{"issue":"9921","key":"1821_CR31","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/s0140-6736(13)61752-3","volume":"383","author":"SS Mahmood","year":"2014","unstructured":"Mahmood SS, Levy D, Vasan RS, Wang TJ (2014) The framingham heart study and the epidemiology of cardiovascular disease: a historical perspective. Lancet 383(9921):999\u20131008. https:\/\/doi.org\/10.1016\/s0140-6736(13)61752-3","journal-title":"Lancet"},{"issue":"2","key":"1821_CR32","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s40258-017-0310-5","volume":"15","author":"NJ Devlin","year":"2017","unstructured":"Devlin NJ, Brooks R (2017) Eq-5d and the euroqol group: past, present and future. Appl Health Econ Health Policy 15(2):127\u2013137. https:\/\/doi.org\/10.1007\/s40258-017-0310-5","journal-title":"Appl Health Econ Health Policy"},{"issue":"1","key":"1821_CR33","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00270-021-02954-7","volume":"45","author":"N Hafezi-Nejad","year":"2022","unstructured":"Hafezi-Nejad N, Gullotti DM, Bailey CR, Lessne ML, Holly BP (2022) Does intraprocedural ct improve the success rate of adrenal venous sampling? A systematic review and meta-analysis of data from 809 patients. Cardiovasc Intervent Radiol 45(1):29\u201340. https:\/\/doi.org\/10.1007\/s00270-021-02954-7","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"4","key":"1821_CR34","doi-asserted-by":"publisher","first-page":"409","DOI":"10.2478\/raon-2020-0052","volume":"54","author":"T Kocjan","year":"2020","unstructured":"Kocjan T, Jensterle M, Vidmar G, Vrckovnik R, Berden P, Stankovic M (2020) Adrenal vein sampling for primary aldosteronism: a 15-year national referral center experience. Radiol Oncol 54(4):409\u2013418. https:\/\/doi.org\/10.2478\/raon-2020-0052","journal-title":"Radiol Oncol"},{"issue":"2","key":"1821_CR35","doi-asserted-by":"publisher","first-page":"89","DOI":"10.5152\/dir.2018.17397","volume":"24","author":"H Jakobsson","year":"2018","unstructured":"Jakobsson H, Farmaki K, Sakinis A, Ehn O, Johannsson G, Ragnarsson O (2018) Adrenal venous sampling: the learning curve of a single interventionalist with 282 consecutive procedures. Diagn Interv Radiol 24(2):89\u201393. https:\/\/doi.org\/10.5152\/dir.2018.17397","journal-title":"Diagn Interv Radiol"},{"key":"1821_CR36","doi-asserted-by":"publisher","first-page":"e136","DOI":"10.5114\/pjr.2019.84178","volume":"84","author":"T Chayovan","year":"2019","unstructured":"Chayovan T, Limumpornpetch P, Hongsakul K (2019) Success rate of adrenal venous sampling and predictors for success: a retrospective study. Pol J Radiol 84:e136\u2013e141. https:\/\/doi.org\/10.5114\/pjr.2019.84178","journal-title":"Pol J Radiol"},{"issue":"7","key":"1821_CR37","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1210\/js.2019-00131","volume":"3","author":"N Wada","year":"2019","unstructured":"Wada N, Shibayama Y, Yoneda T, Katabami T, Kurihara I, Tsuiki M, Ichijo T, Ogawa Y, Kawashima J, Sone M, Yoshimoto T, Matsuda Y, Fujita M, Kobayashi H, Tamura K, Kamemura K, Otsuki M, Okamura S, Naruse M (2019) Lateralizing asymmetry of adrenal imaging and adrenal vein sampling in patients with primary aldosteronism. J Endocr Soc 3(7):1393\u20131402. https:\/\/doi.org\/10.1210\/js.2019-00131","journal-title":"J Endocr Soc"},{"issue":"3","key":"1821_CR38","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/jhh.2016.61","volume":"31","author":"K Kamemura","year":"2017","unstructured":"Kamemura K, Wada N, Ichijo T, Matsuda Y, Fujii Y, Kai T, Fukuoka T, Sakamoto R, Ogo A, Suzuki T, Umakoshi H, Tsuiki M, Naruse M (2017) Significance of adrenal computed tomography in predicting laterality and indicating adrenal vein sampling in primary aldosteronism. J Hum Hypertens 31(3):195\u2013199. https:\/\/doi.org\/10.1038\/jhh.2016.61","journal-title":"J Hum Hypertens"},{"issue":"5","key":"1821_CR39","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s00268-005-0622-8","volume":"30","author":"YY Tan","year":"2006","unstructured":"Tan YY, Ogilvie JB, Triponez F, Caron NR, Kebebew EK, Clark OH, Duh QY (2006) Selective use of adrenal venous sampling in the lateralization of aldosterone-producing adenomas. World J Surg 30(5):879\u2013885. https:\/\/doi.org\/10.1007\/s00268-005-0622-8 (Discussion 886-877)","journal-title":"World J Surg"},{"issue":"2","key":"1821_CR40","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1001\/jamasurg.2020.5011","volume":"156","author":"JW Thiesmeyer","year":"2021","unstructured":"Thiesmeyer JW, Ullmann TM, Stamatiou AT, Limberg J, Stefanova D, Beninato T, Finnerty BM, Vignaud T, Leclerc J, Fahey TJ 3rd, Brunaud L, Mirallie E, Zarnegar R (2021) Association of adrenal venous sampling with outcomes in primary aldosteronism for unilateral adenomas. JAMA Surg 156(2):165\u2013171. https:\/\/doi.org\/10.1001\/jamasurg.2020.5011","journal-title":"JAMA Surg"},{"issue":"9","key":"1821_CR41","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1507\/endocrj.ej11-0133","volume":"58","author":"T Nishikawa","year":"2011","unstructured":"Nishikawa T, Omura M, Satoh F, Shibata H, Takahashi K, Tamura N, Tanabe A (2011) Guidelines for the diagnosis and treatment of primary aldosteronism\u2013the Japan endocrine society 2009. Endocr J 58(9):711\u2013721. https:\/\/doi.org\/10.1507\/endocrj.ej11-0133","journal-title":"Endocr J"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-022-01821-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-022-01821-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-022-01821-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T13:55:39Z","timestamp":1662731739000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-022-01821-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,25]]},"references-count":41,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["1821"],"URL":"https:\/\/doi.org\/10.1007\/s40618-022-01821-7","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,25]]},"assertion":[{"value":"5 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose. The authors have no conflicts of interest to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Our study does not incorporate any human subjects or identifiable patient information. Thus\u00a0Rutgers University Institutional Review Board regulations deem it exempt from obtaining Review Board approval.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was also not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}